Bushu Pharma provides contract manufacturing services for the production of granules, powders, tablets and capsules, Plain tablets, Film-coated tablets, Sugar-coated tablets, Multi-layer tablets, Orally disintegrating tablets, Hard capsules and more
Our recently launched Gateway to Asia service allows you to import bulk products into Japan for quality inspection, labeling, packaging and distribution across Japan and to other Asian countries. Cut down on lead time and inventory management with our Asia Hub Solution.
Ensuring your product has no defects is essential to your success in any market. Bushu Pharma has built its expertise in Visual Inspection. We have the know-how and equipment to expertly conduct inspection of your product – checking for visual defects of both the product and packaging.
We accommodate the strong expansion of temperature-controlled bio-pharmaceuticals (2 to 8°C) for the global markets. One is Misato Cold Chain Center (498 pallets), the new cold chain center for packaging & storage, and another is Kawagoe Cold storage warehouse (500 pallets).
Japan’s premier CDMO.
Offering the best in Pharmaceutical Manufacturing & Supply Chain solutions.
Proven Track-record + Global Capabilities
Years as CDMO
GMP Global Certifications
Percent International Sales
Bushu Pharma will participate in the upcoming 24th INTERPHEX JAPAN 2022 for the first time in three years. Set to take place on July 13 – 15 at the Tokyo Big Sight convention center, numerous companies involved in the production of pharmaceutical products will exhibit at the show. Bushu Pharma will introduce the facilities, plants, and services that have been added to our capabilities over the past three years.
Hideyuki Tanaka – Bushu Pharma’s Head of Global Business Development and Marketing Strategy – will be a guest speaker at the 7th Pharma Supply Chain and Logistics Innovation Programme, taking place on 10-11 May 2022 in Basel, Switzerland. His session entitled “GATEWAY to ASIA – effective supply chain management approaching to Asian market for your innovative drugs”…
Notice Concerning Conclusion of Business Transfer Agreement: Sanwa Kagaku Kenkyusho’s Fukushima Factory Business Transferring to Bushu Pharmaceuticals
Sanwa Kagaku Kenkyusyo CO., LTD. (President / CEO: Shusaku Isono, Suzuken Group; hereinafter referred to as “Sanwa Kagaku”) today announced that it has signed an agreement with Bushu Pharmaceuticals Ltd.（Tetsuichi Okada, CEO / Executive Chairman） for the transfer of business of Fukushima Factory.
On March 10, 2022, Bushu Pharma President and COO Tadao Takano gave a special lecture at Interphex Week Osaka addressing the supply chain of pharmaceutical manufacturers based on the latest global GDP standards.